Your browser doesn't support javascript.
loading
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10.
Wainberg, Zev A; Fuchs, Charles S; Tabernero, Josep; Shitara, Kohei; Muro, Kei; Van Cutsem, Eric; Bang, Yung-Jue; Chung, Hyun Cheol; Yamaguchi, Kensei; Varga, Eniko; Chen, Jen-Shi; Hochhauser, Daniel; Thuss-Patience, Peter; Al-Batran, Salah-Eddin; Garrido, Marcelo; Kher, Uma; Shih, Chie-Schin; Shah, Sukrut; Bhagia, Pooja; Chao, Joseph.
Afiliação
  • Wainberg ZA; Department of the Division of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California. zwainberg@mednet.ucla.edu.
  • Fuchs CS; Department of Medical Oncology, Yale Cancer Center, Smilow Cancer Hospital, New Haven, Connecticut.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Van Cutsem E; University Hospitals and KU Leuven, Leuven, Belgium.
  • Bang YJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea (South).
  • Chung HC; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea (South).
  • Yamaguchi K; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Varga E; Department of Oncology, Debreceni Egyetem Klinikai Központ, Debrecen, Hungary.
  • Chen JS; Department of Hematology, Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Tao-Yuan, Taiwan.
  • Hochhauser D; Department of Medical Oncology, UCL Cancer Institute, London, United Kingdom.
  • Thuss-Patience P; Department of Hematology, Oncology, and Tumor Immunology, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany.
  • Al-Batran SE; Deparment of Tumor Diseases, Institut für Klinisch-Onkologische, Frankfurt, Germany.
  • Garrido M; Department of Hematology and Medical Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Kher U; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, New Jersey.
  • Shih CS; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, New Jersey.
  • Shah S; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, New Jersey.
  • Bhagia P; Department of Medical Oncology, Merck & Co., Inc., Kenilworth, New Jersey.
  • Chao J; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
Clin Cancer Res ; 27(7): 1923-1931, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33446564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Junção Esofagogástrica / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Junção Esofagogástrica / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article